Live Breaking News & Updates on Hich Is Encouraging As The Company Looks To Takea Leap In Peripheral Artery Disease Pad Treatment Initiated By University Hospitals Jena And Leipzig Germany Led Principal Investigator Pi Prof Dr Ulf Teichgraber Alongside Co Thomas Zeller Dierk Scheinert

Munster, [Germany], July 30 (ANI/PRNewswire): LIMES (Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of SiroLIMus Drug-Coated Balloon versus Standard Angioplasty for the Treatment of Infrapopliteal Occlusions in Patients with PEripheral Arterial DiSease) has already enrolled 15 patients, which is encouraging as the Company looks to take a leap in the peripheral artery disease (PAD) treatment. Initiated by the University Hospitals Jena and Leipzig in Germany and led by Principal Investigator (PI) Prof. Dr Ulf Teichgraber alongside Co-PI Prof. Thomas Zeller and Prof. Dierk Scheinert, LIMES is a prospective, multicentre, randomized controlled trial (RCT) which is designed and aimed to evaluate Magic Touch - PTA 0.014" and 0.018" (Concept Medical Inc) versus POBA (Plain Old Balloon Angioplasty) in a head-to-head comparison (1:1). The trial kicked off with the index patient enrolled on 31st March 2022 by PD Dr Nassan Malyar at the Universit ....

United States , Thomas Zeller , Nassan Malyar , Ulf Teichgraber , Dierk Scheinert , University Hospital Munster , Concept Medical Inc , University Hospitals Jena , Drug Administration , Drug Coated Balloon , Standard Angioplasty , Infrapopliteal Occlusions , Arterial Disease , Principal Investigator , Magic Touch , Plain Old Balloon Angioplasty , Breakthrough Device , Coated Balloon , Breakthrough Device Designation , Uly 30 Ani Prnewswire Limes Prospective Multi Center Randomized Controlled Trial To Evaluate The Safety And Efficacy Of Sirolimus Drug Coated Balloon Versus Standard Angioplasty For Treatment Infrapopliteal Occlusions In Patients With Peripheral Arterial Disease Has Already Enrolled 15 , Hich Is Encouraging As The Company Looks To Takea Leap In Peripheral Artery Disease Pad Treatment Initiated By University Hospitals Jena And Leipzig Germany Led Principal Investigator Pi Prof Dr Ulf Teichgraber Alongside Co Thomas Zeller Dierk Scheinert , Imes Isa Prospective , Andomized Controlled Trial Rct Which Is Designed And Aimed To Evaluate Magic Touch Pta 0 014 Quot 018 Concept Medical Inc Versus Poba Plain Old Balloon Angioplasty Ina Head Comparison 1 The Kicked Off With Index Patient Enrolled On 31st March 2022 By Pd Dr Nassan Malyar At University Hospital Munster In Germany Limes Set Enrol 230 Patients , Andomized In 1 Magic Touch Pta Poba Fashion Currently 19 Centres Across Germany And Austria The Patient Population Will Include Patients Presenting With Documented Chronic Critical Limb Ischemia Cli Target Defined As Rutherford Clinical Category Rcc 4 , O Lesion Length Limitation And No In Number Of Used Devices Follow Up Will Be Per House Visits At 30 Days , 4 And 36 Months The Rct Will Measure Efficacy Of Sirolimus Coated Balloons Ina Complex Setting Clti Pad Segment Located Below P3 Popliteal Artery To Tibiotalar Joint Against Current Standard Care ,